Kao JH - Search Results

1

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao JH, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson AM, Voss F, Gallivan JP, Böcher WO, Ferenci P. Jensen DM, et al. Among authors: kao jh. Ann Hepatol. 2016 May-Jun;15(3):333-49. doi: 10.5604/16652681.1198803. Ann Hepatol. 2016. PMID: 27049487 Free article.

2

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.

Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Liu CJ, et al. Among authors: kao jh. Hepatology. 2003 Mar;37(3):568-76. doi: 10.1053/jhep.2003.50096. Hepatology. 2003. PMID: 12601355

3

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis.

Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS, Chen PJ. Yeh SH, et al. Among authors: kao jh. J Hepatol. 2004 Oct;41(4):659-66. doi: 10.1016/j.jhep.2004.06.031. J Hepatol. 2004. PMID: 15464248

4

Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity.

Hsieh TH, Kao JH, Lai MY, Chen PJ, Chen DS. Hsieh TH, et al. Among authors: kao jh. J Formos Med Assoc. 2005 May;104(5):354-8. J Formos Med Assoc. 2005. PMID: 15959603

5

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, Kao JH, Chen DS. Liu CJ, et al. Among authors: kao jh. J Hepatol. 2005 Aug;43(2):235-42. doi: 10.1016/j.jhep.2005.02.044. J Hepatol. 2005. PMID: 15964656

6

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Liu CJ, et al. Among authors: kao jh. Hepatology. 2006 Apr;43(4):742-9. doi: 10.1002/hep.21100. Hepatology. 2006. PMID: 16557544 Clinical Trial.

7

Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.

Yang SS, Fu LS, Chang CS, Yeh HZ, Chen GH, Kao JH. Yang SS, et al. Among authors: kao jh. J Gastroenterol Hepatol. 2006 Dec;21(12):1789-93. doi: 10.1111/j.1440-1746.2006.04677.x. J Gastroenterol Hepatol. 2006. PMID: 17074015

8

Pegylated interferons for the treatment of chronic hepatitis B.

Liu CJ, Kao JH. Liu CJ, et al. Among authors: kao jh. Recent Pat Antiinfect Drug Discov. 2006 Jan;1(1):85-94. doi: 10.2174/157489106775244154. Recent Pat Antiinfect Drug Discov. 2006. PMID: 18221137 Review.

9

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: kao jh. Clin Infect Dis. 2008 Nov 15;47(10):1260-9. doi: 10.1086/592579. Clin Infect Dis. 2008. PMID: 18834319 Clinical Trial.

10

The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.

Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH. Tsai YH, et al. Among authors: kao jh. J Hepatol. 2008 Dec;49(6):899-907. doi: 10.1016/j.jhep.2008.06.030. Epub 2008 Sep 16. J Hepatol. 2008. PMID: 18842320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page